GenSight Biologics S.A. (GSGTF)

GenSight Biologics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 30, 2024	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	39	34	28	166	290	372
Market Cap Growth	20.63%	20.63%	-82.90%	-42.89%	-21.99%	308.86%
Enterprise Value	58	51	51	157	250	371
Last Close Price	0.24	0.24	0.47	3.15	6.75	8.59
PS Ratio	14.40	12.59	8.66	31.90	33.13	40.91
PB Ratio	-1.40	-1.23	-0.84	-10.16	15.97	25.91
P/TBV Ratio	-	-	-	-	16.09	26.20
EV/Sales Ratio	19.47	18.59	15.53	30.25	28.53	40.80
Debt / Equity Ratio	-0.71	-0.71	-0.77	-1.17	1.10	1.63
Asset Turnover	0.26	0.26	0.17	0.12	0.15	0.19
Quick Ratio	0.20	0.20	0.18	0.96	2.18	2.41
Current Ratio	0.24	0.24	0.26	1.57	2.40	2.56
Return on Equity (ROE)	-	-	-	-7781.69%	-206.34%	-305.52%
Return on Assets (ROA)	-99.39%	-99.39%	-105.83%	-42.13%	-33.80%	-39.03%
Return on Capital (ROIC)	-	-	-	-96.45%	-54.62%	-59.68%
Earnings Yield	-37.03%	-42.36%	-102.16%	-17.80%	-11.21%	-11.18%
FCF Yield	-34.22%	-39.14%	-96.14%	-21.91%	-6.72%	-4.95%
Buyback Yield / Dilution	-98.18%	-98.18%	-4.29%	-2.61%	-28.54%	-23.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.